Hepatitis C virus (HCV) infection is the most frequently reported bloodborne infection in the United States and a leading cause of liver-related morbidity, transplantation, and mortality.
1 Transmission of HCV occurs through exposure to infected body fluids, principally blood. Untreated, between 15% and 42% of infected persons resolve infection
2-4; about half of those chronically infected develop progressive liver disease, which may include cirrhosis and hepatocellular carcinoma.
5,6 Approximately 18 000 people died in 2016 because of HCV infection.
5-7 Historically, HCV prevalence has been highest among persons in the birth cohort born between 1945 and 1965, and the number of people living with chronic infection was estimated to be 3.5 million in the late 2000s.
8,9